Cargando…
Case report: Long-term survival of a pancreatic cancer patient immunized with an SVN-2B peptide vaccine
A 62-year-old woman who underwent surgery to treat pancreatic cancer provided written, informed consent to undergo adjuvant therapy with gemcitabine, tegafur, and uracil. However, this was stopped after only 14 days due to Grade 4 neutropenia. She was then started on vaccine therapy with Survivin 2B...
Autores principales: | Shima, Hiroaki, Kutomi, Goro, Satomi, Fukino, Imamura, Masafumi, Kimura, Yasutoshi, Mizuguchi, Toru, Watanabe, Kazue, Takahashi, Akari, Murai, Aiko, Tsukahara, Tomohide, Kanaseki, Takayuki, Hirohashi, Yoshihiko, Iwayama, Yuji, Tsuruma, Tetsuhiro, Kameshima, Hidekazu, Sato, Noriyuki, Torigoe, Toshihiko, Takemasa, Ichiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182403/ https://www.ncbi.nlm.nih.gov/pubmed/30069687 http://dx.doi.org/10.1007/s00262-018-2217-x |
Ejemplares similares
-
Flap revascularization in patients following immediate reconstruction using an autologous free dermal fat graft for breast cancer: a report of two cases
por: Shima, Hiroaki, et al.
Publicado: (2016) -
Heat shock protein 90 targets a chaperoned peptide to the static early endosome for efficient cross-presentation by human dendritic cells
por: Tanaka, Tsutomu, et al.
Publicado: (2015) -
ST6GALNAC1 plays important roles in enhancing cancer stem phenotypes of colorectal cancer via the Akt pathway
por: Ogawa, Tadashi, et al.
Publicado: (2017) -
Development of a T‐cell receptor multimer with high avidity for detecting a naturally presented tumor‐associated antigen on osteosarcoma cells
por: Watanabe, Kazue, et al.
Publicado: (2018) -
Randomized phase II trial of survivin 2B peptide vaccination for patients with HLA‐A24‐positive pancreatic adenocarcinoma
por: Shima, Hiroaki, et al.
Publicado: (2019)